What we found on the web about HMG-CoA Reductase
HMG-CoA reductase (or 3-hydroxy-3-methyl-glutaryl-CoA reductase or HMGR) is the rate-controlling enzyme (EC 1.1.1.88) of the mevalonate pathway, the metabolic pathway that produces ...
The mevalonate pathway or HMG-CoA reductase pathway or mevalonate-dependent (MAD) route or isoprenoid pathway, is an important cellular metabolic pathway present in all higher ...
HMG-CoA reductase inhibitors, also referred to as "statins," are a family of drugs used to reduce high blood levels of cholesterol and LDL ("bad") cholesterol, and to a lesser ...
Oral chelation can reverse symptoms of heart disease. This is a very brief presentation of the data for which more than 8,000 pages have now been published.
Thesaurus Legend: Synonyms Related Words Antonyms. Noun: 1. HMG-CoA reductase - a liver enzyme that is responsible for producing cholesterol. 5-hydroxy-3-methylglutaryl-coenzyme A ...
Hmg-Coa Reductase Inhibitors patient information. Detailed drug information for the consumer, includes dosage, Hmg-Coa Reductase Inhibitors side effects and more.
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:2046-2050 Published online before print September 23, 2004, doi: 10.1161/01.ATV.0000145943 ...
HMG-CoA reductase inhibitors, also referred to as "statins," are a family of drugs used to reduce high blood levels of cholesterol and LDL ("bad") cholesterol, and to a lesser ...
The HMG-CoA reductase gene spans about 24 200 base pairs on chromosome 5q13.3 (July 2003 human genome assembly, National Center for Biotechnology Information build 34) with an ...
1: J Clin Pharmacol. 1993 Mar;33(3):226-9. Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study.
Here is what users have to say about HMG-CoA Reductase

HMG-CoA reductase (or 3-hydroxy-3-methyl-glutaryl-CoA reductase or HMGR) is the rate-controlling enzyme ( ) of the mevalonate pathway, the metabolic pathway that produces cholesterol and other isoprenoids. This enzyme is the target of the widely available cholesterol-lowering drugs known collectively as the statins. HMG-CoA reductase is anchored in the membrane of the endoplasmic reticulum, and was long regarded as having seven transmembrane domains, with the active site located in a long carboxyl terminal domain in the cytosol. More recent evidence shows it to contain eight transmembrane domains.

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!